Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-10

Clinical Trial Update: PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) [Phase 2]

View source ↗

Summary

Phase 2 trial update for PNT2258 in Richter's transformation has been terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PNT2258

Snippet

Sponsor: Sierra Oncology LLC - a GSK company | Conditions: Richter's Transformation | Phase 2 | Status: TERMINATED | Results posted: 2020-03-10